ONCOSIL MEDICAL LTD - Announcements

1.80%

$1.09

Market Cap $20.51M

Healthcare Biotechnology

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

OSL	OncoSil Medical appoints Natalie Ruffles		13/02/14	403.98KB	Share
OSL	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/14	250.84KB	Share
OSL	OncoSil Medical Ltd - Investor Update		17/01/14	727.88KB	Share
OSL	Notice of Extraordinary General Meeting/Proxy Form		06/01/14	361.74KB	Share
OSL	Notice of Extraordinary General Meeting/Proxy Form		06/12/13	211.91KB	Share
OSL	ASX Listing Rule 10.13.3		06/12/13	284.07KB	Share
OSL	Amended Appendix 3Y		05/12/13	183.84KB	Share
OSL	Institutional Investor Presentation US FDA		05/12/13	1.14MB	Share
OSL	Change of Director's Interest Notice		03/12/13	234.83KB	Share
OSL	Appendix 3B		04/11/13	388.93KB	Share
OSL	Becoming a substantial holder		31/10/13	215.34KB	Share
OSL	Appendix 3B		29/10/13	517.76KB	Share
OSL	Change of Director's Interest Notice		29/10/13	230.32KB	Share
OSL	Change of Director's Interest Notice		29/10/13	234.57KB	Share
OSL	Appendix 3B		29/10/13	383.6KB	Share
OSL	Change of Director's Interest Notice		29/10/13	382.85KB	Share
OSL	Change of Director's Interest Notice		29/10/13	377.87KB	Share
OSL	Change of Director's Interest Notice		29/10/13	378.25KB	Share
OSL	Results of Meeting		28/10/13	383.99KB	Share
OSL	Chairman's Address AGM		28/10/13	179.05KB	Share
OSL	Placement capacity under ASX Listing Rule 7.1		28/10/13	111.61KB	Share
OSL	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/13	236.11KB	Share
OSL	Share Purchase Plan Successfully Completed		23/10/13	271.69KB	Share
OSL	US patent for OncoSil granted by the US PTO	PRICE SENSITIVE	18/10/13	272.21KB	Share
OSL	Change of Director's Interest Notice		16/10/13	230.38KB	Share
OSL	Ceasing to be a substantial holder		01/10/13	64.5KB	Share
OSL	Ceasing to be a substantial holder		25/09/13	283.05KB	Share
OSL	Ceasing to be a substantial holder		24/09/13	1.06MB	Share
OSL	Results of Meeting		24/09/13	127.55KB	Share
OSL	Change in substantial holding		23/09/13	460.4KB	Share
OSL	Shareholder Share Purchase Plan		20/09/13	179.68KB	Share
OSL	Appendix 3B		20/09/13	240.33KB	Share
OSL	Notice of Annual General Meeting/Proxy Form		20/09/13	211.14KB	Share
OSL	Change of Director's Interest Notice		18/09/13	73.95KB	Share
OSL	Final Director's Interest Notice		13/09/13	218.5KB	Share
OSL	OncoSil raised $10million for Pancreatic Cancer Study	PRICE SENSITIVE	13/09/13	400.93KB	Share
OSL	Trading Halt	PRICE SENSITIVE	11/09/13	279.95KB	Share
OSL	OncoSil Medical Investor Update		10/09/13	2.72MB	Share
OSL	Amended Appendix 3B		10/09/13	551.79KB	Share
OSL	Appendix 4E and Annual Report	PRICE SENSITIVE	30/08/13	1.19MB	Share
OSL	New Financial Controller & Joint Company Secretary		23/08/13	275.54KB	Share
OSL	Notice of Extraordinary General Meeting/Proxy Form		22/08/13	106.02KB	Share
OSL	Response to ASX Price Query	PRICE SENSITIVE	16/08/13	330.25KB	Share
OSL	Becoming a substantial holder		16/08/13	148.19KB	Share
OSL	US FDA Gap Analysis	PRICE SENSITIVE	08/08/13	405.29KB	Share
OSL	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/13	225.86KB	Share
OSL	OncoSil initiates global strategic manufacturing alliance	PRICE SENSITIVE	23/07/13	133.05KB	Share
OSL	CEO Presentation		18/07/13	3.49MB	Share
OSL	Response to ASX Price Query	PRICE SENSITIVE	12/07/13	330.13KB	Share
OSL	Final Director's Interest Notice		03/07/13	218.55KB	Share
OSL	Initial Director's Interest Notice		03/07/13	220.22KB	Share
OSL	Appointment of CEO & change of address	PRICE SENSITIVE	02/07/13	342.8KB	Share
OSL	Change of Director's Interest Notice		05/06/13	295.21KB	Share
OSL	Appendix 3B		05/06/13	552.61KB	Share

OSLOncoSil Medical appoints Natalie Ruffles
13/02/14		403.98KB	Share
OSLAppendix 4C - quarterly
29/01/14	PRICE SENSITIVE	250.84KB	Share
OSLOncoSil Medical Ltd - Investor Update
17/01/14		727.88KB	Share
OSLNotice of Extraordinary General Meeting/Proxy Form
06/01/14		361.74KB	Share
OSLNotice of Extraordinary General Meeting/Proxy Form
06/12/13		211.91KB	Share
OSLASX Listing Rule 10.13.3
06/12/13		284.07KB	Share
OSLAmended Appendix 3Y
05/12/13		183.84KB	Share
OSLInstitutional Investor Presentation US FDA
05/12/13		1.14MB	Share
OSLChange of Director's Interest Notice
03/12/13		234.83KB	Share
OSLAppendix 3B
04/11/13		388.93KB	Share
OSLBecoming a substantial holder
31/10/13		215.34KB	Share
OSLAppendix 3B
29/10/13		517.76KB	Share
OSLChange of Director's Interest Notice
29/10/13		230.32KB	Share
OSLChange of Director's Interest Notice
29/10/13		234.57KB	Share
OSLAppendix 3B
29/10/13		383.6KB	Share
OSLChange of Director's Interest Notice
29/10/13		382.85KB	Share
OSLChange of Director's Interest Notice
29/10/13		377.87KB	Share
OSLChange of Director's Interest Notice
29/10/13		378.25KB	Share
OSLResults of Meeting
28/10/13		383.99KB	Share
OSLChairman's Address AGM
28/10/13		179.05KB	Share
OSLPlacement capacity under ASX Listing Rule 7.1
28/10/13		111.61KB	Share
OSLAppendix 4C - quarterly
25/10/13	PRICE SENSITIVE	236.11KB	Share
OSLShare Purchase Plan Successfully Completed
23/10/13		271.69KB	Share
OSLUS patent for OncoSil granted by the US PTO
18/10/13	PRICE SENSITIVE	272.21KB	Share
OSLChange of Director's Interest Notice
16/10/13		230.38KB	Share
OSLCeasing to be a substantial holder
01/10/13		64.5KB	Share
OSLCeasing to be a substantial holder
25/09/13		283.05KB	Share
OSLCeasing to be a substantial holder
24/09/13		1.06MB	Share
OSLResults of Meeting
24/09/13		127.55KB	Share
OSLChange in substantial holding
23/09/13		460.4KB	Share
OSLShareholder Share Purchase Plan
20/09/13		179.68KB	Share
OSLAppendix 3B
20/09/13		240.33KB	Share
OSLNotice of Annual General Meeting/Proxy Form
20/09/13		211.14KB	Share
OSLChange of Director's Interest Notice
18/09/13		73.95KB	Share
OSLFinal Director's Interest Notice
13/09/13		218.5KB	Share
OSLOncoSil raised $10million for Pancreatic Cancer Study
13/09/13	PRICE SENSITIVE	400.93KB	Share
OSLTrading Halt
11/09/13	PRICE SENSITIVE	279.95KB	Share
OSLOncoSil Medical Investor Update
10/09/13		2.72MB	Share
OSLAmended Appendix 3B
10/09/13		551.79KB	Share
OSLAppendix 4E and Annual Report
30/08/13	PRICE SENSITIVE	1.19MB	Share
OSLNew Financial Controller & Joint Company Secretary
23/08/13		275.54KB	Share
OSLNotice of Extraordinary General Meeting/Proxy Form
22/08/13		106.02KB	Share
OSLResponse to ASX Price Query
16/08/13	PRICE SENSITIVE	330.25KB	Share
OSLBecoming a substantial holder
16/08/13		148.19KB	Share
OSLUS FDA Gap Analysis
08/08/13	PRICE SENSITIVE	405.29KB	Share
OSLAppendix 4C - quarterly
31/07/13	PRICE SENSITIVE	225.86KB	Share
OSLOncoSil initiates global strategic manufacturing alliance
23/07/13	PRICE SENSITIVE	133.05KB	Share
OSLCEO Presentation
18/07/13		3.49MB	Share
OSLResponse to ASX Price Query
12/07/13	PRICE SENSITIVE	330.13KB	Share
OSLFinal Director's Interest Notice
03/07/13		218.55KB	Share
OSLInitial Director's Interest Notice
03/07/13		220.22KB	Share
OSLAppointment of CEO & change of address
02/07/13	PRICE SENSITIVE	342.8KB	Share
OSLChange of Director's Interest Notice
05/06/13		295.21KB	Share
OSLAppendix 3B
05/06/13		552.61KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.09		Change -0.020(1.80%)		Mkt cap ! $20.51M

Open	High	Low	Value	Volume
$1.11	$1.12	$1.08	$19.98K	18.08K

Buyers (Bids)

No.	Vol.	Price($)
3	3196	$1.08

Sellers (Offers)

Price($)	Vol.	No.
$1.09	3598	1

View Market Depth

No.	Vol.	Price($)
3	3196	1.080
2	2011	1.070
1	77	1.065
3	5442	1.060
2	2654	1.050

Price($)	Vol.	No.
1.090	3598	1
1.115	1875	1
1.140	5000	1
1.150	6938	1
1.180	5000	1

Last trade - 16.10pm 08/08/2025 (20 minute delay)

OSL (ASX) Chart

ONCOSIL MEDICAL LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories